The p53 protein is a transcription factor involved in processes of cell growth and dierentiation. The muscle creatine kinase (MCK) gene whose transcription is induced during muscle dierentiation contains p53-binding sites. In this study we tested the involvement of p53 in the activation of MCK transcription during muscle dierentiation of C2 cells. We have shown that the p53 protein is stabilized and its DNA binding and transcriptional activities are induced during muscle dierentiation. At the stage of muscle-dierentiation, p53 protein can induce the accurate transcription of a minimal p53-dependent MCK reporter gene. Moreover, p53 cooperates with MyoD in the induction of MCK transcription. The expression of a dominant negative p53 protein in muscle cells reduced the expression of endogenous MCK gene. The dominant negative p53 protein abolished the cooperativity of wild type p53 with MyoD. Amino and carboxy terminal residues of MyoD required for the cooperation with p53 in transcription were identi®ed. The cooperativity between the two proteins occurs also at the stage of DNA binding. We suggest that p53 protein is activated during myoblast dierentiation and participates with MyoD in the induction of MCK transcription.
Introduction
The p53 gene encodes a nuclear phospho-protein which functions as a tumor suppressor by negative regulation of cell cycle progression and the induction of apoptosis (Finlay et al., 1989; Chen et al., 1990; Gottlieb and Oren, 1996; Ko and Prives, 1996; Levine, 1997) . p53 is also involved in the regulation of cell dierentiation (Prokocimer and Rotter, 1994; Rotter et al., 1994) . Increased activity or expression of p53 protein was observed in processes such as hematopoiesis (Kastan et al., 1991b; Shaulsky et al., 1991; Aloni-Grinstein et al., 1995) spermatogenesis (Almon et al., 1993) and myogenesis (Soddu et al., 1996) .
The involvement of p53 in muscle dierentiation is controversial. On the one hand, p53-null mice developed normally and exhibited normal muscle dierentiation (Donehower et al., 1992) . Fibroblast cells, derived from p53-null mice were converted to muscle cells as a result of the ectopic expression of MyoD (Halevy et al., 1995) . On the other hand, interference with the endogenous wild type p53 protein in an established muscle cell line showed a striking reduction in the ability of these cells to dierentiate (Soddu et al., 1996) . The apparent con¯ict may be explained if p53 is replaced by the presence of a redundant activity in the animal. The redundant function, however, cannot be activated in the context of already determined cell lines. In fact, a new gene, p73, with signi®cant amino acid and functional similarities to p53 was recently identi®ed (Jost et al., 1997) .
p53 protein functions as a transcription factor that binds to speci®c DNA sequences and activates gene transcription (Kern et al., 1991; Farmer et al., 1992) . Between the genes that have been identi®ed as speci®c targets for p53 protein are p21/WAF, MDM2, GADD45, cyclin G and bax, whose products function as regulators of cell growth (reviewed by Ko and Prives, 1996; Levine, 1997) . p53 can activate the transcription of genes that are involved in differentiation ± the k light chain gene in B cell dierentiation (Aloni-Grinstein et al., 1995) and the muscle creatine kinase (MCK) gene in muscle dierentiation (Weintraub et al., 1991c) .
The MCK gene is induced after myoblast cells have undergone cell-cycle arrest and during terminal dierentiation. Two groups of muscle-speci®c transcription factors were shown to be involved in the transcription of MCK. The ®rst is the MyoD family that is involved in the activation of many musclespeci®c genes and therefore plays a pivotal role in driving the myogenic developmental process (reviewed in Weintraub et al., 1991a) . The second is the MEF2 family that is not speci®c to muscle but plays an important role in the transcription of many musclespeci®c genes, including myogenin that belongs to the MyoD family. Members of the MyoD and MEF2 families activate MCK transcription by binding to nearby DNA sequences that are located in the enhancer region (reviewed in Olson et al., 1995) .
Weintraub and colleagues demonstrated in transient transfection experiments that p53 activated the transcription of MCK reporter gene (Weintraub et al., 1991c) . Activation was dependent on the presence of a sequence of 500 nucleotides found 2800 to 3300 base pairs upstream to the transcription start site. Subsequent studies identi®ed a 50 bp fragment within this sequence (73182 to 73133, relative to transcription start site) to which p53 could bind (Zambetti et al., 1992) . The 50 bp fragment was shown to act like an enhancer element in its ability to induce transcrip-tion from heterologous promoters (Zambetti et al., 1992) . Recent studies have identi®ed a second p53 responsive element located between promoter residues 7177 and 781, relative to transcription start site. This p53-binding element was suggested to cooperate with the more distal binding site to allow a distinct activation of MCK promoter by p53 protein (Jackson et al., 1995) .
Despite the identi®cation of p53 DNA binding sites within the MCK regulatory sequences, the role for p53 in activation of MCK during muscle dierentiation remains to be determined. In this study we show that p53 protein is stabilized and its DNA binding and transcriptional activities are induced during differentiation of C2 cells. During this stage the endogenous p53 protein induced the accurate transcription of a minimal p53-dependent MCK reporter gene. The expression of a dominant negative form of p53 in muscle cells reduced the expression of the endogenous MCK gene. Finally, in gel shift experiments and in transient transfection experiments, we show that p53 cooperates with MyoD in DNA binding and in transcription, respectively.
Results

Wild type p53 protein is expressed and stabilized in dierentiating C2 cells
The murine C2 myoblast cell line dierentiates into multinucleated myotubes after serum withdrawal at which stage the transcription of muscle creatine kinase (MCK) gene is induced. Our goal was to elucidate the involvement of p53 in the transcriptional activation of MCK. We ®rst con®rmed the status of the endogenous p53 in these cells by immunoprecipitating the protein with antibodies that recognize the wild type conformation (PAb 246) or a mutant conformation (PAb 240). By this criteria, C2 cells express the wild type protein (Figure 1a ) (Soddu et al., 1996) . The wild type conformation was con®rmed also by the DNA binding and the transcriptinal activities of the protein. From the metabolic labeling of p53 we learn that the rate of synthesis of p53 is lower in dierentiating myotubes relative to proliferating myoblasts ( Figure 1a, lanes 3,  4) . To analyse the steady state level of p53 protein in the same cells, the protein was immunoprecipitated from extracts, and then analysed by the Western technique (Figure 1b) . Except for small variations, the protein level does not change during the dierentiation process. The apparent discrepancy between steady state levels of p53 protein and the rate of its synthesis in myoblasts and myotubes suggests that the half life of the protein may be upregulated during dierentiation. p53 protein usually has a very short half-life, but it was shown to acquire higher stability under distinct physiological conditions (Kastan et al., 1991a; Kuerbitz et al., 1992) . We therefore undertook to analyse the half-life of p53 at dierent stages of dierentiation. A pulse-chase experiment suggested that p53 protein had a short half-life of about 20 ± 30 min in dividing myoblasts (Figure 2 ). The half-life of p53 increased to 50 ± 60 min in cells grown in DM for 48 h (Figure 2 ). The longer half-life of p53 at this stage may explain why the S-methionine and proteins were immunoprecipitated with PAb 240 that recognizes the mutant conformation of p53 or with PAb 246 that recognizes the wild type conformation of p53. (b) C2 cells were allowed to dierentiate in DM for dierent lengths of time. Proteins were extracted from cells. p53 protein was immunoprecipitated from these extracts, then applied on SDS ± PAGE and determined in Western analysis (see Materials and methods). RNA was extracted from cells and the level of dierent transcripts was determined by Northern analysis Figure 2 The half-life of p53 protein is extended in differentiating myotubes. (a) C2 cells were grown as myoblasts in growth medium or as myotubes after they were transferred to dierentiation medium for 48 h. Proteins were pulse-labeled for 40 min by the addition of 35 S-methionine to cell media. The labeling of proteins was chased by replacement of the medium with unlabeled medium. Cells were lysed and proteins were extracted following the indicated chase time points. p53 protein was immunoprecipitated and analysed over SDS ± PAGE. (b) The amount of labeled p53 at any time point of the pulse-chase experiment presented in a was quanti®ed by the phosphoimager. The relative amounts of p53 at any chase period are presented steady state levels of the protein do not match the rate of its synthesis in myotubes.
The DNA binding and transcriptional activities of p53 protein are induced during muscle dierentiation
To participate in the transcription of MCK, p53 is expected to be active during muscle dierentiation. MCK gene exhibits the same pattern of expression as that of MLC2 (data not shown; see Figure 1 ). One transcription factor that participates in MCK transcription is MyoD whose activity is induced at early stages of dierentiation (Lassar et al., 1989) . To study the potential role of p53 in the activation of MCK, a DNA fragment of 59 base pairs, containing the distal p53 element of MCK (Zambetti et al., 1992) , was used as a probe for DNA binding of p53 from protein extracts derived from C2 cells at dierent stages of dierentiation. The 59 base pairs DNA fragment was immobilized on magnetic beads, and extracts were incubated with the immobilized DNA. Beads were thoroughly washed and p53 protein that was bound to the beads was detected by Western analysis ( Figure  3a ). Low amounts of p53 protein derived from extracts of myoblasts were bound to the distal MCK site. A signi®cantly higher amount of p53 derived from extracts of myotubes grown in DM for 48 h was bound to the distal MCK site. The binding was greatly reduced in extracts from myotubes that were grown for 96 h in DM (Figure 3a ). This pattern of binding was not due to dierent amounts of p53 protein in these extracts, as can be seen in Figure 3a (lower panel). The experiment suggests that the DNA binding activity of p53 protein is induced in dierentiating myo®bers regardless of the protein levels that do not change. Another approach was used to evaluate the transcriptional activity of p53 in dierentiating C2 cells. For that purpose, the same distal p53 element or a mutated distal element that was not recognized by p53 were separately fused to a mimimal MCK promoter (780 to +7, relative to transcription start site). Transient transfection assays have con®rmed that only the reporter gene that contained the original p53 distal element was speci®cally induced by exogenous transfected p53 (data not shown). To study the possible involvement of the p53 element in the timely expression of MCK, each of the reporter plasmids was transfected together with a selectable gene (puromycin resistance) into C2 cells, and drug resistant colonies were pulled together. Two polyclones were studied; one that contained the wild type p53 reporter gene, and the other that contained the mutated p53 reporter gene (Figure 3b ). The amount of integrated reporter gene was analysed by Southern analysis and was found to be similar in both pulls (data not shown). Cells that contained the integrated reporter gene of wild type p53 binding site expressed low chloramphenicol acetyl transferase (CAT) activity in myoblasts ( Figure 3b ). CAT activity was induced in myotubes grown in DM for 48 h (Figure 3b ). Cells that contained the mutated reporter did not exhibit any CAT activity, although, these cells contained the integrated reporter gene ( Figure 3b and data not shown). Based on these results we suggest that p53 DNA binding and transcriptional activities are induced in dierentiating C2 cells. The activity of p53 alone can induce the transcription of a minimal MCK promoter containing the distal p53 site.
Dominant negative p53 inhibits the expression of MCK
To further evaluate the possible role of p53 in the expression of MCK, we used dominant negative mini protein of p53 (Shaulian et al., 1992) . The mini protein is a short C-terminal fragment of p53 that can complex with wild type p53 and inhibit its activities (p53-DD) (Shaulian et al., 1992) . A second peptide that was used as a control for the dominant negative peptide is a derivative of p53-DD containing an in-frame deletion of the`core oligomerization domain' (p53-DDSS) (deletion of amino acids 330-344). This peptide cannot interact and interfere with the activity of the wild type protein. The expression vectors of each of the mutated peptides or wild type p53 were transiently transfected to C2 myoblasts that were allowed to dierentiate. To identify the transfected cells, and to learn how the expression of p53 mutants aected MCK expression, immunochemical staining of cells was performed. Cells Extracts from C2 cells that were grown in the presence of DM for the indicated period of time were incubated with beads that contained the p53 distal element of MCK. The beads were washed extensively to remove unbound proteins, and the proteins bound to the beads were separated over SDS ± PAGE and analysed by Western technique with antibodies to p53 (PAb 421) (upper panel). The same protein extracts were used in an immunoprecipitation followed by Western analysis with antibodies to p53 (PAb 421) (lower panel). (b) Stable C2 cell lines that have integrated two reporter genes, a minimal MCK promoter with the distal element of p53 (wt-p53/-80MCK-CAT) or a minimal MCK promoter with a mutated element of p53 (mut-p53/-80MCK-CAT) were obtained as described under Materials and methods. The lines were grown as myoblasts and as myotubes after 48 h in DM, and proteins were extracted. Identical amounts of proteins were used in both CAT assays. The conversion of chloramphenicol to its acetylated forms was quanti®ed in the phosphor imager were double-stained with anti p53 monoclonal antibodies, and anti MCK polyclonal antibodies ( Figure  4 ). This staining procedure did not identify the endogenous p53 protein (data not shown), however, the ectopic expression of exogenous p53 proteins was identi®ed. p53-DD was localized in nuclei of transfected cells that in most cases did not express detectable levels of MCK (Figure 4a and b). Transfected cells that expressed the dominant negative protein (p53-DD) did not exhibit the morphology of myo®bers and did not express MHC, and therefore did not undergo full dierentiation (not shown). The p53-DDSS protein was distributed between the nucleus and the cytoplasm of transfected cells, and appeared to colocalize at much higher frequencies in multinucleated cells that also expressed MCK (Figure 4a and b) . Similarly, the transfected wild type p53 protein was localized in the nuclei and was co-expressed with MCK in the same cells at distinctly higher rates than the p53-DD mutant (Figure 4a and b) . Therefore, the p53-DD mutant appears to interfere with the whole myogenic program of C2 cells.
Ectopic expression of MyoD in NIH3T3 ®broblast cells converts them to muscle cells that express muscle-speci®c genes (Weintraub et al., 1991a) . To study the eect of dominant negative p53 protein in another cellular system, we transfected NIH3T3 ®broblasts with MyoD and p53 proteins. The transfected cells were immunostained to identify the expression of MCK or the expression of MHC ( Figure  4c ). Expression of p53-DD repressed dramatically the percentage of transfected cells that expressed MCK, but did not aect the expression of MHC (Figure 4c ). Co-expression of a control p53 protein, p53-DDSS with MyoD did not aect the expression of MCK or MHC. This result suggests that inhibition of p53 in these cells, unlike in C2 cells abolished selectively the expression of MCK and not of MHC.
The distal p53 binding site cooperates with the enhancer element of MCK Previous studies have de®ned an enhancer element that can induce the temporal expression of MCK in dierentiating muscle cells (Jaynes et al., 1988) . The results, presented in Figure 3 , suggest that the distal p53 element can also induce MCK during the same stages (see Figure 3b) . Next, we asked whether the two Figure 4 Inhibition of endogenous expression of MCK by p53-DD mini protein in C2 cells. (a) C2 myoblasts were transiently transfected with either p53-DD (dominant negative), p53-DDSS (dominant negative control) or wild type p53 expression vectors. Cells were grown in dierentiation medium for 48 h after which they were ®xed and double stained for MCK with¯uourescein and for p53 with rhodamine. Cells were examined at 6200 magni®cation. (b) Quanti®cation of the transfection experiment described in a. For each experiment, about 100 p53-transfected cells were counted, and the percentage of MCK stained cells was calculated. The graph represents the average of two independent experiments. (c) NIH3T3 ®broblasts were transiently transfected with MyoD expression vector, or with MyoD and either p53-DD or p53-DDSS expression vectors. Cells were grown in dierentiation medium for 48 h after which they were ®xed and double stained for MCK and p53 or alternatively for MHC and p53. (Figure 5a ). The transcription of a reporter gene that was regulated by both elements, p53 and enhancer, was signi®cantly induced (56-fold) ( Figure  5a ). These results suggest that the two elements function cooperatively in dierentiating muscle cells.
To study the transcription factors that bind to the enhancer element and cooperate with p53, the enhancer element was further analysed. At least two elements of de®ned transcription factors constitute the MCK enhancer; MEF2 and MyoD (Gossett et al., 1989; Lassar et al., 1989) . Reporter genes that contained each of these sites in conjunction with the p53 distal element were constructed and used in transfection studies of 10T1/2 cells. No signi®cant cooperation in transcription was evident if MEF2C was introduced with p53 into cells transfected with the reporter gene that contained binding sites for both factors (Figure 5b ). Signi®cant cooperation in transcription was evident if MyoD was introduced with p53 into cells transfected with the reporter gene that contained binding sites for these factors (Figure 5b ). When p53 site was deleted from reporter genes, p53 protein repressed the transcriptional activity of MyoD or MEF2C ( Figure  5b ). In earlier studies, p53 protein was demonstrated to repress transcription from promoters that did not have p53 binding sites (Ginsberg et al., 1991; Subler et al., 1992) . p53 protein however did not aect the transcription of the MSV LTR that controlled the expression of MyoD in the transfection studies. This was concluded from the expression of a co-transfected b galactosidase gene that was under the transcriptional control of MSV LTR (data not shown) (see Materials and methods).
Mutants of p53 and MyoD that abolish the cooperativity in transcription
To further elucidate the mechanism of cooperativity between MyoD and p53, mutants of each protein were studied. The p53-DD dominant negative allele was transfected with the wild type p53, to determine if the mutant protein could inhibit the cooperation of wild type protein with MyoD ( Figure 6a ). Expression of p53-DD protein in transfected cells abolished cooperativity in a concentration-dependent manner ( Figure  6a ). The aect of the dominant negative protein was speci®c because the transfected p53-DDSS failed to inhibit the cooperativity between the two proteins ( Figure 6a ). To determine domain(s) of MyoD that participate in the transcriptional cooperation with p53, a series of deletion mutants of MyoD were transfected to NIH3T3 cells with wild type p53. NIH3T3 cells were chosen for this transfection experiment because ectopic expression of MyoD proteins does not activate the transcription of endogenous MyoD that could interfere with the interpretations. Deletion of the amino terminal activation domain (d3-51) or the carboxylterminal residues (tm 270) abolished the cooperation of MyoD with p53 in transcription (Figure 6b ). Deletion of amino acids 63 ± 99 or 170 ± 209 or 218 ± 269 did not aect cooperation with p53. Therefore, two domains may participate in cooperativity of MyoD with p53: the N-terminal activation domain, and the C-terminal domain from residue 270. Unlike MyoD, another family member, myogenin, did not cooperate with wild type p53 in the transfection assay (Figure 6b ). controlled by MCK enhancer element and p53 distal element at dierent combinations were obtained as described under Materials and methods. The lines were grown as myoblasts and for 72 h as myotubes, and proteins were extracted. Identical amounts of proteins were used for the CAT assay. The conversion of chloramphenicol to its acetylated forms was quanti®fed in the phosphoimager and the degree of activation was calculated by dividing the percentage of conversion in myotubes by the percentage of conversion in myoblasts. (b) Dierent reporter genes in which a minimal promoter of MCK (780 to +7, relative to transcritpion initiation site) ws regulated by DNA binding elements of p53, MyoD and MEF2 as illustrated were cotransfected with expression vectors of MyoD, MEF2C and p53 to 10T1/2 ®broblasts. Cells were lysed 48 h after transfection, and extracts were used in chloramphenicol acetyl transferase (CAT) assay according to the transfection eciency that was measured as described in Materials and methods. The chloramphenicol products were separated by thin layer chromatography, and were quanti®ed by phosphor imaging (Fuji). The four histograms share the same arbitrary units but are shown in dierent scales. Average results from two independent experiments are presented
p53 and MyoD proteins cooperate in DNA binding
To further test the idea that the two proteins cooperate, their DNA binding was studied using a DNA probe that contained the distal p53 site and the high anity MyoD binding site of MCK in a gel shift assay. Recombinant MyoD and p53 proteins that were expressed and puri®ed from bacteria and baculo-virus, respectively, were used in the assay. When added separately to the probe, each of the proteins shifted the probe (Figure 7a, lanes 1 and 2) . The binding was speci®c as determined by the competition with unlabeled DNA of homologous binding sites for MyoD and p53 (Figure 7a , lanes 4 to 9). As previously reported, the recombinant p53 protein was almost inactive in site-speci®c DNA binding in the gel-shift assay (Figure 7a, lane 2) . When p53 and MyoD were added concurrently to the probe, a major shifted band that was higher than the bands produced by each of the proteins was evident (Figure 7a, lane 3) . The intensity of this band was signi®cantly higher than that of p53 and similar to that of MyoD, suggesting that the two proteins cooperated in DNA binding. The competition experiment with the unlabeled homologous binding sites of MyoD and p53 that eliminated the higher band suggests that this band represents the simultaneous binding of the two proteins to the probe (Figure 7a, lanes 6 and 9) .
Two deletion mutants of MyoD were used in the binding assay to further establish the cooperativity in DNA binding and to analyse possible domains of MyoD that participate in cooperative binding. One mutant lacked 48 amino-terminal residues (d3-51 MyoD), and the second lacked the same residues and terminated immediately after the basic helix-loop-helix domain (d3-51, tm 167 MyoD). The addition of each of these mutants shifted the DNA probe (Figure 7b , lanes 4 and 6). However, the addition of p53 to each of these mutants did not produce any signi®cantly higher shifted bands, as observed with the wild type MyoD protein (Figure 7b , compare lane 3 to lanes 5 and 7). These mutants may even interfere with the binding of p53 to the probe. The results suggest that the deletion of MyoD activation domain alone is sucient to abolish cooperativity with p53 in DNA binding.
Discussion
The muscle creatine kinase gene was one of the ®rst genes shown to contain p53 binding sites, that can mediate transcription by the p53 protein in transient transfection assays (Weintraub et al., 1991c; Zambetti et al., 1992) . However, the involvement of p53 in the activation of MCK promoter during muscle differentiation was not known and made the objective of this study. (62) of pCMV-p53-DD and pCMVp53-DDSS were transfected. Cells were lysed 48 h after transfection, and extracts were used in the chloramphenicol acetyl transferase (CAT) assay according to the transfection eciency that was measured as described in Materials and methods. The chloramphenicol products were separated by thin layer chromatography, and were quanti®ed by phosphor imaging (Fuji). Average results from two independent experiments are presented. Error bars show standard deviations. (b) The same reporter gene as in (a) was co-transfected with expression vectors of p53 and several deletion mutants of MyoD to NIH3T3 cells. Three micrograms of each plasmid were used to transfect cells. Cells were processed, and CAT assay was done as described in (a). Average results from two independent experiments are presented. Error bars show standard deviations Figure 7 Cooperative DNA binding between MyoD and p53 proteins. (a) Recombinant MyoD and p53 proteins were bound to a DNA probe that contained a binding site for each protein and analysed in a gel-shift assay as described in Materials and methods. Unlabeled ds oligonucleotides that contained p53 or MyoD binding sites were added to some reactions in 100-fold excess over the DNA probes. (b) Wild type MyoD protein or dierent recombinant mutants of MyoD were added with wild type p53 in a DNA binding reaction as in (a). The d3-51 mutant is a MyoD protein that lacks amino acids 3 to 51. The d3-51 tm 167 mutant is a MyoD protein that lacks amino acids 3-51 and terminates at amino acid 167
As a ®rst step, we undertook to study the expression and activity of p53 in dierentiating muscle cells. Although the synthesis of p53 protein declined during dierentiation, the steady state levels of p53 protein did not change signi®cantly (Figure 1) , probably due to a slower turnover of the protein (Figure 2) . We found that the half-life of the protein increased from 20 ± 30 min to about an hour (Figure 2) . Moreover, the DNA binding and transcriptional activity of p53 protein increased signi®cantly during dierentiation (Figure 3) . The increase in stability and activity of p53 appears to occur simultaneously, and therefore may result from a single change such as phosphorylation or acetylation of the protein Lane, 1994, 1995; Gu and Roeder, 1997) . Changes in p53 stability and activity in response to dierent physiological conditions were previously demonstrated. p53 protein becomes very stable and accumulates in response to DNA damage induced by UV radiation (Lu et al., 1996) . In keratinocyte dierentiation and in differentiation of teratocarcinoma cells, like in muscle, the levels of p53 mRNA decreased, however, the transcriptional activity of the protein increased (Weinberg et al., 1995; Lutzker and Levine, 1996) . In the dierentiation process of cells associated with the central nervous system, the subcellular localization of p53 changes: during dierentiation it appears mainly in the nucleus, whereas in mature dierentiated cells it is present mainly in the cytoplasm (Eizenberg et al., 1996) . The mechanisms involved in these changes are unknown at present. A recent study has shown that enhanced phosphorylation of p53 in cells treated with okadaic acid was correlated with an enhanced transcriptional activity of the protein (Lohrum and Scheidtmann, 1996) . p53 protein can also be acetylated on its carboxyl-terminal domain (Gu and Roeder, 1997) . Acetylation of p53 can dramatically stimulate its sequence-speci®c DNA-binding activity. Studies in our laboratory are under way to elucidate the changes in p53 protein during muscle dierentiation.
Our subsequent studies were aimed at examining if the increased activity of p53 in dierentiating cells aected the transcription of MCK. The activity of a minimal MCK promoter that contained the distal p53 element was analysed in C2 cells and was found to be induced during dierentiation (Figure 3b ). We propose that the transcriptional induction of this reporter gene is p53-speci®c because mutations in the element that abolished p53 binding rendered the promoter inactive. A correlation was found to exist between the transcriptional activity of the minimal MCK promoter and the in vitro binding of p53 to the distal element suggesting that transcription of MCK was induced as a result of the enhanced DNA activity of p53 (Figure 3) . Additional supporting evidence for the induction of p53 activity in muscle cells was recently presented (Soddu et al., 1996) . Soddu and colleagues (1996) studied p53 in dierentiating C2 cells by measuring the transcription of an integrated p53 reporter gene and observed a similar peak of p53 transcriptional activity to the one that we found for its DNA binding activity ( Figure 3a) . As the distal p53 element is part of a complex regulatory transcription unit, we tested the relationship between the distal p53 element and other elements of this unit. One well-studied regulatory element is the enhancer found at 1050 ± 1250 nucleotides upstream from the transcription start site. The enhancer element itself can induce the transcription of MCK in dierentiating myotubes ( Figure 5 ) (Jaynes et al., 1988) . Nevertheless, the enhancer and p53 elements combined induced the transcription of MCK in a cooperative manner (Figure 5a ). At least two elements of de®ned transcription factors are found in the enhancer, MEF2 and MyoD (Lassar et al., 1989; Gossett et al., 1989) . Each element was separately placed with the distal p53 element to control a minimal MCK reporter gene (Figure 5b ). Cooperative transcription could be determined by transfection of 10T1/ 2 ®broblasts with expression vectors of the dierent transcription factors. MEF2C, which participates in the transcription of many muscle genes, did not cooperate with p53 on a minimal promoter that contained both binding sites. MyoD, on the other hand, cooperated with p53 on a minimal promoter that contained both binding sites (Figure 5b ). The cooperativity of p53 and MyoD suggests that the two proteins may interact. The p53 protein was shown to interact physically with transcription factors and to repress their activities. Such interactions were demonstrated with the TATA binding protein (TBP), the CCAAT binding factor (CBF) and the thyroid hormone nuclear receptor (TR) (Ago et al., 1993; Truant et al., 1993; Farmer et al., 1996; Yap et al., 1996) . Unlike the other transcription factors, p53 cooperates with MyoD to induce transcription. The DNA binding experiments suggest that cooperativity between MyoD and p53 occurs at the level of protein-protein interactions (Figure 7) .
Mutants of both proteins were studied in transfection experiments to further establish the cooperativity between them (Figure 6 ). The dominant negative mini protein of p53 (DD-p53) was able to completely block the cooperativity of wild type p53 with MyoD without aecting the activity of MyoD (Figure 6 ). The speci®c activity of this mutant con®rms the direct involvement of p53 in the cooperative activity. Several deletion mutants of MyoD that abolished cooperation with p53, but not the transcriptional activity of MyoD itself, con®rm the involvement of MyoD in the cooperative activity. MyoD mutants that do not display cooperativity are those that lack either the 50 N-terminal residues or the 50 C-terminal residues (Figure 6b) . The 50 N-terminal residues are highly acidic, and function as a transactivation domain (Weintraub et al., 1991b) . This domain also participates in cooperative binding between MyoD proteins bound at nearby DNA binding sites (EB unpublished results). Therefore, this domain probably participates in protein-protein interactions with other transcription factors.
The role of p53 in the transcription of MCK was further studied by the introduction of the p53 dominant negative mini-protein into C2 cells. In agreement with the study of Soddu and colleagues (1996) , we found an overall inhibitory eect of the dominant negative protein on muscle dierentiation (Figure 4a and b) . Therefore, in C2 cells committed to the myogenic lineage, interference with the endogenous p53 protein inhibited not only MCK expression but the overall dierentiation process. However, the dominant negative p53 eect in transfected ®broblasts was more speci®c (Figure 4c ). The expression of p53-DD in transfected ®broblasts inhibited the activity of MyoD in induction of MCK, but not of MHC. Therefore, in this cellular system, inhibition of p53 aected the expression of MCK but most probably not the expression of other muscle speci®c genes. This experiment suggests the speci®c involvement of p53 in the expression of the endogenous MCK gene. However, the complex eects of p53 throughout the whole myogenic program observed with C2 cells proves that p53 is also involved in other aspects of cell dierentiation that are not known so far.
Materials and methods
Plasmids
The MCK reporter gene pe+AT-CAT is described in Jaynes et al. (1986) . Other MCK reporter genes were constructed as follows: p-80-MCK-CAT: p-3,300 MCK-CAT was digested with ApaI and HindIII to delete most of the regulatory sequences, blunt ended and religated. Wtp53/-80 MCK-CAT and Mut-p53/-80 MCK-CAT were constructed by ligating a 59 ds oligonucleotide of the distal p53 site or the mutated p53 site, respectively, to the p-80 MCK-CAT that was linearized with HindIII and then blunt-ended. Wt-p53-e+AT-CAT: The 59 fragment of p53 binding site was inserted to pe+AT-CAT (Jaynes et al., 1986 ) that was linearized with HindIII and blunt ended. To create pMyoD-p53-80MCK-CAT, pMEF2p53-80MCK-CAT and pMyoD-80MCK-CAT fragments that contained the regulatory and the CAT sequences of Wt-p53-80 MCK-CAT or p-80 MCK-CAT were subcloned into pBluescript KS + (BamHI ± EcoRV). Double-stranded oligonucleotides of the MyoD right site or the MEF2 site both of the MCK enhancer, were inserted to the HindIII site of pBS-p53-80 MCK-CAT or pBS-80 MCK-CAT. The expression plasmids of p53-pCMV-p53, pCMV-DD and pCMV-DDSS, are described elsewhere and were kindly provided by M Oren from the Weizmann Institute (Shaulian et al., 1992) . Expression plasmids of MyoD; tm167, tm270 are described elsewhere and were kindly provided by S Tapscott, Fred Hutchinson Center, Seattle, WA. pEMSVmyogenin and MEF2C expression vectors were kindly provided by E Olson, U of Texas Southwestern Medical Center at Dallas.
Cell culture
C2 cells were a gift of Dr David Yae (Yae and Saxel, 1977) . 10T1/2 and NIH3T3 cells were obtained from ATCC. Stable C2 cell lines of reporter genes were generally prepared as follows: The designated reporter gene was co-transfected together with pBABE-puro into C2 cells. Cells resistant to puromycin were selected by incubation with 3 mg/ml of puromycin (Sigma) for 7 days. Usually tens to hundreds of clones were obtained and pooled together. Stable clones were frozen in liquid nitrogen and thawed as needed. All cell lines were maintained in Dulbecco's Modi®ed Eagle's Medium (DMEM) supplemented with 15% calf serum (Hyclone), penicillin, and streptomycin (Growth Medium; GM). To induce dierentiation we used DMEM supplemented with 10 mg of insulin per ml and 10 mg of transferring per ml (Dierentiation medium; DM).
Transfections and CAT assays
Transfections were performed by calcium phosphate precipitation as described (Davis et al., 1990) . Cells in 6 cm TC dishes (Corning) were transfected for 12 h with a total amount of 10 mg of the following plasmid DNA: 1 mg pCMV-LacZ or pMSV-LacZ, 3 mg of CAT reporter gene, 3 mg expression plasmid of MyoD (wt or mutants) and 3 mg of expression vector of p53 (wt or mutants).`Empty vectors' of pCDNA3 or EMSV that contained the CMV promoter and MSV LTR respectively, were added if necessary to bring plasmid DNA to a ®nal amount of 10 mg. Following transfection the medium was replaced for another 24 ± 48 h. Cells were extracted and protein extracts were used to measure b galactosidase and chloramphenicol acetyl transferase activities. The ecienty of transfections was tested in soluble b-galactosidase assays as described and the amount of extracts used for the CAT assays was corrected accordingly (Gorman et al., 1982) . Each transfection experiment was repeated at least twice and the average values were plotted in graphs.
Estimation of p53 protein half-life (pulse chase experiments) C2 myoblasts or myotubes (48 h in DM) were incubated in methionine free medium for 40 min and then labeled with 100 mCi/ml 35 S-methionine for 40 min. The proteins of one plate were extracted (pulse; time 0) and the medium in four other plates was replaced with 5 ml of GM (myoblasts) or DM (myotubes). Proteins were extracted at various intervals (20, 40, 60 min) in lysis buer (50 mM Tris-HCl pH 7.9, 15 mM NaCl, 5 mM EDTA, 0.5% NP40 and protease inhibitors) and p53 was immunoprecipitated as follows: at each time point equal amounts of proteins were incubated with pre-immune serum and 20 ml of protein A sepharose (1 : 1) for 1 h. Supernatant was collected and incubated with PAb 421 and PAb 248 for 1 h on ice. Protein A sepharose (30 ml, 1 : 1), was added for an additional hour of rotation at 48C. Beads were washed three times in one milliliter of high-salt buer (50 mM TrisHCl pH 7.4, 0.5 M NaCl, 5 mM EDTA, 1% NP40, 5% Sucrose) and twice in low salt buer (10 mM Tris-HCl pH 7.4, 0.1% NP40, 5 mM EDTA) (1 ml, each wash). Finally SDS sample buer was added to beads and proteins were analysed over SDS ± PAGE.
Immunohistochemical staining
Transfected cells were washed three times in phosphatebuered saline (PBS), ®xed in 2% paraformaldehyde for 7 min, washed three times in PBS, and permeabilyzed in 0.25% Triton X-100 for 10 min. Then cells were incubated with the primary antibody for 90 min. Primary antibodies used were monoclonal anti p53 (PAb 421), polyclonal anti MCK (a gift from S Tapscott) and polyclonal MHC (Sigma). After being washed three times in PBS, the cells were incubated for 90 min with a secondary antibody conjugated to¯uorescein isothiocyanate or to rhodamine (Jackson IRL). Cells were washed three times in PBS. The ®nal wash contained 1 ng of 4',6-diamidino-2-phenylindole (DAPI) per ml. The immunochemically stained cells were viewed at 6200 magni®cation under a¯uorescence microscope, Olympus (model BX50).
RNA analysus
Cells were harvested and RNA was extracted with the Tri Reagent solution (Molecular Research Center Inc.) according to the manufacturer's directions. Total RNA (5 mg) was used for Northern blot analysis on 1.5% agarose gels containing 6.7% formaldehyde. Gels were capillary-transferred to Magna nylon membrane by MSI and were UV crosslinked. Blots were hybridized with probes for MLC2 (PVZLC2) and GAPDH (pMGAP) that were prepared with random hexamers and Klenow reaction. Hybridization was conducted overnight at 658C in a buer containing 0.2 M sodium phosphate buer, 1 mM EDTA, 1% bovine serum albumin and 7% SDS (hybridization buer). Blots were washed at 608C in 0.56SSC (16SC is 0.15 M NaCl, 0.015 M sodium citrate) and 0.1% SDS, three times for 15 min each time. Blots were stripped by boiling for 5 min in 0.1% SDS solution.
Immunoprecipitation-Western analysis of p53
Cells were lysed and equal amounts of extracted proteins were ®rst immunoprecipitated as described above using monoclonal anti p53 (PAb 421) and then were separated over SDS ± PAGE. Proteins were transferred from gel to nitrocellulose ®lters. p53 protein was detected by a cocktail of PAb 421 and PAb 248. Proteins were visualized using the Amersham chemiluminescence kit.
Immobilized DNA binding of p53
Proteins were extracted from C2 cells grown as myoblasts or as myotubes. The protein extracts (6 mg/reaction) were incubated with magnetic beads (Dynabeads) to which the 59 base pair distal p53 fragment of MCK was attached via biotin-avidin interactions. Ten microliters of beads (500 ng of the DNA fragment) were used in each reaction. The reaction was performed in the presence of 3 mg poly d(I-C):poly d(I-C) and in the following buer conditions: 20 mM Tris-HCl pH 7.2, 100 mM NaCl, 10% glycerol, 1% NP40 and 5 mM EDTA. The beads were rotated at 48C for 2 h, after which they were washed four times with washing buer (20 mM Tris-HCl pH 7.2, 100 mM NaCl, 2% glycerol, 1% NP40, 5 mM EDTA). Proteins that remained bound to the beads were released in SDS sample buer, separated over SDS ± PAGE and blotted onto nitrocellulose. p53 was analysed as described above.
Gel shift assay DNA probe preparation An oligonucleotide containing one high anity MyoD binding site from the MCK enhancer and the p53 distal element of MCK of the following sequence was synthesized: 5'-GGGATCCTGG-CAAGCCTA TGACATGG CCGGGGCTGCCTCTCTCT-GCCTCTGACCCTCCCCGCCAACACCTGCTGCCCTC-GAATTCC-3'. The second strand was synthesized by annealing of a primer 5'-GGAATTCGAGGG-3' and extension with labeled 32 P-dCTP and three unlabeled deoxyribonucleosides (dATP, dGTP, dTTP) in a Klenow reaction.
Proteins preparation Wild type p53 protein expressed in a baculovirus system was a gift from M Oren (Regimove et al., 1993) . MyoD proteins (wild type and deletion mutants) were expressed in bacteria and puri®ed as described (Thayer and Weintraub, 1993; Bengal et al., 1994) . MyoD and p53 proteins were incubated in mix solution (65: 10 mM MgCl 2 , 0.1% NP40, 0.5 mg/ml BSA and 10 mM spermidin) and in BC-100 (62: 40 mM HEPES pH 7.9, 100 mM KCl, 0.2 mM EDTA, 20% Glycerol). The recombinant puri®ed factors added were: MyoD at 200 ng/reaction and p53 at 100 ng/reaction. Labeled double-stranded oligonucleotide (50 000 c.p.m., *0.5 ng) was added together with 500 ng poly d(I-C):poly d(I-C) to the reaction mixture. If cold homologous oligonucleotides (competitors) were added, they were incubated with proteins on ice for 30 min before the addition of DNA probe. DNA and proteins were incubated for 30 min in 308C. Complexes were separated over 4% native gel (0.256TBE). Gel was electrophoresed at constant 20 mA for 2 h in the cold room (48C), then vacuum dried and exposed to Fuji ®lms for 2 ± 3 h.
